Savara Inc
SVRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001160308
No open-market purchases or sales by Savara Inc insiders were filed in the last 90 days; 180 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Savara Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 124
- −13 vs. Q1 2025
- Shares held
- 167.7M
- +2.57M (+1.6%) vs. Q1 2025
- Total value
- $382.3M
- −$75.1M (−16.4%) vs. Q1 2025
- New holders
- 13
- 48 more added
- Sold out
- 26
- 36 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SVRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 180 | $1.34B |
| Q1 2026 | 185 | $1.16B |
| Q4 2025 | 148 | $1.21B |
| Q3 2025 | 126 | $581.9M |
| Q2 2025 | 124 | $382.3M |
| Q1 2025 | 137 | $457.3M |
| Q4 2024 | 136 | $499.9M |
| Q3 2024 | 126 | $680.4M |
| Q2 2024 | 133 | $597.4M |
| Q1 2024 | 120 | $602.9M |
| Q4 2023 | 98 | $559.2M |
| Q3 2023 | 84 | $441.2M |
| Q2 2023 | 77 | $284.8M |
| Q1 2023 | 69 | $162.9M |
| Q4 2022 | 55 | $124.0M |
| Q3 2022 | 56 | $123.9M |
| Q2 2022 | 54 | $117.4M |
| Q1 2022 | 53 | $99.4M |
| Q4 2021 | 54 | $92.6M |
| Q3 2021 | 59 | $103.6M |
| Q2 2021 | 75 | $129.6M |
| Q1 2021 | 83 | $156.5M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Savara Inc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Charles Schwab Investment Management Inc | 995,511 | $2.27M | 0.00% | +40,681+4.3% | Added |
| AXA S.A. | 1,050,126 | $2.39M | 0.01% | +1,685+0.2% | Added |
| Northern Trust Corp | 1,069,656 | $2.44M | 0.00% | +13,478+1.3% | Added |
| Superstring Capital Management LP | 1,115,379 | $2.54M | 3.17% | +149,176+15.4% | Added |
| Sphera Funds Management Ltd. | 1,310,233 | $2.99M | 0.78% | +26,082+2.0% | Added |
| Emerald Mutual Fund Advisers Trust | 2,186,404 | $4.99M | 0.30% | +171,948+8.5% | Added |
| State Street Corp | 2,456,941 | $5.60M | 0.00% | +7,290+0.3% | Added |
| Sofinnova Investments, Inc. | 2,457,352 | $5.60M | 0.38% | −3,024,314−55.2% | Reduced |
| Rosalind Advisors, Inc. | 2,654,944 | $6.05M | 2.93% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 2,970,183 | $6.77M | 0.00% | +147,946+5.2% | Added |
| Wellington Management Group LLP | 3,350,272 | $7.64M | 0.00% | −812,381−19.5% | Reduced |
| Emerald Advisers, LLC | 3,534,368 | $8.06M | 0.30% | +444,155+14.4% | Added |
| ADAR1 Capital Management, LLC | 3,600,670 | $8.21M | 1.33% | +2,240,379+164.7% | Added |
| Farallon Capital Management, L.L.C. | 6,835,000 | $15.6M | 0.07% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 7,964,000 | $18.2M | 0.33% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 8,325,375 | $19.0M | 1.34% | +250,000+3.1% | Added |
| Vanguard Group Inc | 8,453,980 | $19.3M | 0.00% | +334,733+4.1% | Added |
| VR Adviser, LLC | 8,884,263 | $20.3M | 1.52% | +5,626,624+172.7% | Added |
| BlackRock, Inc. | 9,775,573 | $22.3M | 0.00% | −170,738−1.7% | Reduced |
| Vestal Point Capital, LP | 11,015,000 | $25.1M | 1.32% | +15,000+0.1% | Added |
| Frazier Life Sciences Management, L.P. | 11,462,301 | $26.1M | 1.05% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 12,362,205 | $28.2M | 3.22% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 17,600,621 | $40.1M | 5.02% | 00.0% | Unchanged |
| NEA Management Company, LLC | 24,471,264 | $55.8M | 4.20% | 00.0% | Unchanged |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −836,397−100.0% | Sold out |
| Readystate Asset Management LP | 0 | $0 | 0.00% | −522,791−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −256,594−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −207,299−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −115,752−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −75,350−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −67,094−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −65,200−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −59,003−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −52,209−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −27,200−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −26,661−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −22,376−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −16,516−100.0% | Sold out |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −12,588−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −12,116−100.0% | Sold out |
| SIH Partners, LLLP | 0 | $0 | 0.00% | −10,847−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −10,550−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −945−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −781−100.0% | Sold out |
| Private Wealth Management Group, LLC | 0 | $0 | 0.00% | −606−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −329−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −335−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −114−100.0% | Sold out |
| Rothschild Investment LLC | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −20−100.0% | Sold out |